Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: liposomal daunorubicin citrate
Sponsor: University of Leicester